Uncoupling between enhanced excitation-contraction coupling and the response to heart disease: Lessons from the PI3Kγ knockout murine model

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 4, 2011, Pages 606-612

  Guo, Danny ^a   Thiyam, Gayatri ^a   Bodiga, Sreedhar ^a   Kassiri, Zamaneh ^a   Oudit, Gavin Y ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiomyopathy; Cell adhesion; Excitation contraction coupling; Mechanotransduction; Signaling

Indexed keywords

CALCIUM ION; CYCLIC AMP; MATRIX METALLOPROTEINASE; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA;

ANIMAL MODEL; CALCIUM CELL LEVEL; CELL ADHESION; EXCITATION CONTRACTION COUPLING; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HUMAN; INTRACELLULAR SPACE; KNOCKOUT MOUSE; MECHANICAL STRESS; MECHANOTRANSDUCTION; MORPHOLOGY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; SIGNAL TRANSDUCTION; SYSTOLIC DYSFUNCTION; UPREGULATION;

ANIMALS; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; EXCITATION CONTRACTION COUPLING; HEART DISEASES; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL;

ANIMALIA; MURINAE; MUS;

EID: 79952073678     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.01.011     Document Type: Review

References (90)

1. Mudd J.O., Kass D.A. Tackling heart failure in the twenty-first century. Nature 2008 Feb 21, 451(7181):919-928.
2. Hill J.A., Olson E.N. Cardiac plasticity. N Engl J Med 2008 Mar 27, 358(13):1370-1380.
3. Tirziu D., Giordano F.J., Simons M. Cell communications in the heart. Circulation 2010 Aug 31, 122(9):928-937.
4. Sadoshima J., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997, 59:551-571.
5. Zou Y., Akazawa H., Qin Y., Sano M., Takano H., Minamino T., et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004 Jun, 6(6):499-506.
6. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002 Jan 10, 415(6868):198-205.
7. Pedrotty D.M., Klinger R.Y., Badie N., Hinds S., Kardashian A., Bursac N. Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol 2008 Jul, 295(1):H390-H400.
8. Ervasti J.M. Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 2003 Apr 18, 278(16):13591-13594.
9. Shapiro L., Fannon A.M., Kwong P.D., Thompson A., Lehmann M.S., Grubel G., et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995 Mar 23, 374(6520):327-337.
10. Zuppinger C., Eppenberger-Eberhardt M., Eppenberger H.M. N-Cadherin: structure, function and importance in the formation of new intercalated disc-like cell contacts in cardiomyocytes. Heart Fail Rev 2000 Oct, 5(3):251-257.
11. Matsuda T., Takahashi K., Nariai T., Ito T., Takatani T., Fujio Y., et al. N-cadherin-mediated cell adhesion determines the plasticity for cell alignment in response to mechanical stretch in cultured cardiomyocytes. Biochem Biophys Res Commun 2005 Jan 7, 326(1):228-232.
12. Stokes D.L. Desmosomes from a structural perspective. Curr Opin Cell Biol 2007 Oct, 19(5):565-571.
13. Tran N.L., Adams D.G., Vaillancourt R.R., Heimark R.L. Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem 2002 Sep 6, 277(36):32905-32914.
14. Laprise P., Chailler P., Houde M., Beaulieu J.F., Boucher M.J., Rivard N. Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation. J Biol Chem 2002 Mar 8, 277(10):8226-8234.
15. Lee A.A., Delhaas T., McCulloch A.D., Villarreal F.J. Differential responses of adult cardiac fibroblasts to in vitro biaxial strain patterns. J Mol Cell Cardiol 1999 Oct, 31(10):1833-1843.
16. Simpson D.G., Majeski M., Borg T.K., Terracio L. Regulation of cardiac myocyte protein turnover and myofibrillar structure in vitro by specific directions of stretch. Circ Res 1999 Nov 12, 85(10):e59-e69.
17. Sussman M.A., McCulloch A., Borg T.K. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res 2002 Nov 15, 91(10):888-898.
18. Kassiri Z., Khokha R. Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost 2005 Feb, 93(2):212-219.
19. Berrier A.L., Yamada K.M. Cell-matrix adhesion. J Cell Physiol 2007 Dec, 213(3):565-573.
20. Schwartz M.A., Schaller M.D., Ginsberg M.H. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995, 11:549-599.
21. van Wamel J.E., Ruwhof C., van der Valk-Kokshoorn E.J., Schrier P.I., van der Laarse A. Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts. Pflugers Arch 2000 Apr, 439(6):781-788.
22. Katsumi A., Naoe T., Matsushita T., Kaibuchi K., Schwartz M.A. Integrin activation and matrix binding mediate cellular responses to mechanical stretch. J Biol Chem 2005 Apr 29, 280(17):16546-16549.
23. Ruwhof C., van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000 Jul, 47(1):23-37.
24. MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000 May, 46(2):257-263.
25. White D.E., Coutu P., Shi Y.F., Tardif J.C., Nattel S., St Arnaud R., et al. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev 2006 Sep 1, 20(17):2355-2360.
26. Lu H., Fedak P.W., Dai X., Du C., Zhou Y.Q., Henkelman M., et al. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation 2006 Nov 21, 114(21):2271-2279.
27. Peng X., Wu X., Druso J.E., Wei H., Park A.Y., Kraus M.S., et al. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci USA 2008 May 6, 105(18):6638-6643.
28. Ross R.S., Pham C., Shai S.Y., Goldhaber J.I., Fenczik C., Glembotski C.C., et al. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res 1998 Jun 15, 82(11):1160-1172.
29. Chen H.C., Guan J.L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1994 Oct 11, 91(21):10148-10152.
30. Thamilselvan V., Craig D.H., Basson M.D. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J 2007 Jun, 21(8):1730-1741.
31. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004 Aug, 37(2):449-471.
32. Oudit G.Y., Penninger J.M. Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 2009 May 1, 82(2):250-260.
33. Larsen M., Tremblay M.L., Yamada K.M. Phosphatases in cell-matrix adhesion and migration. Nat Rev Mol Cell Biol 2003 Sep, 4(9):700-711.
34. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 1998 Sep 15, 95(19):11211-11216.
35. Troussard A.A., Tan C., Yoganathan T.N., Dedhar S. Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol Cell Biol 1999 Nov, 19(11):7420-7427.
36. Saunders R.M., Holt M.R., Jennings L., Sutton D.H., Barsukov I.L., Bobkov A., et al. Role of vinculin in regulating focal adhesion turnover. Eur J Cell Biol 2006 Jun, 85(6):487-500.
37. Zemljic-Harpf A.E., Miller J.C., Henderson S.A., Wright A.T., Manso A.M., Elsherif L., et al. Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol 2007 Nov, 27(21):7522-7537.
38. Kumar A., Khandelwal N., Malya R., Reid M.B., Boriek A.M. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 2004 Jan, 18(1):102-113.
39. Khairallah M., Khairallah R., Young M.E., Dyck J.R., Petrof B.J., Des Rosiers C. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol 2007 Aug, 43(2):119-129.
40. Brancaccio M., Fratta L., Notte A., Hirsch E., Poulet R., Guazzone S., et al. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 2003 Jan, 9(1):68-75.
41. De Acetis M., Notte A., Accornero F., Selvetella G., Brancaccio M., Vecchione C., et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ Res 2005 May 27, 96(10):1087-1094.
42. Baurand A., Zelarayan L., Betney R., Gehrke C., Dunger S., Noack C., et al. Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res 2007 May 11, 100(9):1353-1362.
43. Lim B.K., Xiong D., Dorner A., Youn T.J., Yung A., Liu T.I., et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest 2008 Aug, 118(8):2758-2770.
44. Lisewski U., Shi Y., Wrackmeyer U., Fischer R., Chen C., Schirdewan A., et al. The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J Exp Med 2008 Sep 29, 205(10):2369-2379.
45. McKoy G., Protonotarios N., Crosby A., Tsatsopoulou A., Anastasakis A., Coonar A., et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000 Jun 17, 355(9221):2119-2124.
46. Garcia-Gras E., Lombardi R., Giocondo M.J., Willerson J.T., Schneider M.D., Khoury D.S., et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 2006 Jul, 116(7):2012-2021.
47. Naga Prasad S.V., Esposito G., Mao L., Koch W.J., Rockman H.A. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 2000 Feb 18, 275(7):4693-4698.
48. Oudit G.Y., Kassiri Z., Crackower M.A., Penninger J.M., Backx P.H. Loss of PI3 kinase gamma leads to an accelerated progression to dilated cardiomyopathy in response to pressure overload. Circ Suppl 2004, 108:IV-238.
49. Matsuda T., Zhai P., Maejima Y., Hong C., Gao S., Tian B., et al. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc Natl Acad Sci USA 2008 Dec 30, 105(52):20900-20905.
50. Shioi T., McMullen J.R., Tarnavski O., Converso K., Sherwood M.C., Manning W.J., et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003 Apr 1, 107(12):1664-1670.
51. Oudit G.Y., Crackower M.A., Eriksson U., Sarao R., Kozieradzki I., Sasaki T., et al. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 2003 Oct 28, 108(17):2147-2152.
52. Kim Y.K., Kim S.J., Yatani A., Huang Y., Castelli G., Vatner D.E., et al. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem 2003 Nov 28, 278(48):47622-47628.
53. Sun H., Kerfant B.G., Zhao D., Trivieri M.G., Oudit G.Y., Penninger J.M., et al. Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kalpha/PKB signaling. Circ Res 2006 Jun 9, 98(11):1390-1397.
54. Catalucci D., Zhang D.H., DeSantiago J., Aimond F., Barbara G., Chemin J., et al. Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol 2009 Mar 23, 184(6):923-933.
55. Catalucci D., Latronico M.V., Ceci M., Rusconi F., Young H.S., Gallo P., et al. Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17. J Biol Chem 2009 Oct 9, 284(41):28180-28187.
56. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999 Oct 21, 341(17):1276-1283.
57. Chien K.R., Ross J., Hoshijima M. Calcium and heart failure: the cycle game. Nat Med 2003 May, 9(5):508-509.
58. Gwathmey J.K., Yerevanian A.I., Hajjar R.J. Cardiac gene therapy with SERCA2a: From bench to bedside. J Mol Cell Cardiol 2010 Nov 18.
59. Crackower M.A., Oudit G.Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002 Sep 20, 110(6):737-749.
60. Kerfant B.G., Gidrewicz D., Sun H., Oudit G.Y., Penninger J.M., Backx P.H. Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kgamma-deficient mice. Circ Res 2005 May 27, 96(10):1079-1086.
61. Oudit G.Y., Kassiri Z. Role of PI3 kinase gamma in excitation-contraction coupling and heart disease. Cardiovasc Hematol Disord Drug Targets 2007 Dec, 7(4):295-304.
62. Patrucco E., Notte A., Barberis L., Selvetella G., Maffei A., Brancaccio M., et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 2004 Aug 6, 118(3):375-387.
63. Guo D., Kassiri Z., Basu R., Chow F.L., Kandalam V., Damilano F., et al. Loss of PI3K{gamma} Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress. Circ Res 2010 Sep 16.
64. Guo D., Kassiri Z., Basu R., Chow F.L., Kandalam V., Damilano F., et al. Loss of PI3K{gamma} Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress. Circ Res 2010 Nov 12, 107(10):1275-1289.
65. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007 Oct, 87(4):1285-1342.
66. Covington M.D., Burghardt R.C., Parrish A.R. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Ren Physiol 2006 Jan, 290(1):F43-F51.
67. Dwivedi A., Slater S.C., George S.J. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 2009 Jan 1, 81(1):178-186.
68. Kostetskii I., Li J., Xiong Y., Zhou R., Ferrari V.A., Patel V.V., et al. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 2005 Feb 18, 96(3):346-354.
69. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003 Jul, 4(7):566-577.
70. Janczewski A.M., Zahid M., Lemster B.H., Frye C.S., Gibson G., Higuchi Y., et al. Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. Cardiovasc Res 2004 Jun 1, 62(3):468-480.
71. Kiriazis H., Sato Y., Kadambi V.J., Schmidt A.G., Gerst M.J., Hoit B.D., et al. Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis. Cardiovasc Res 2002 Feb 1, 53(2):372-381.
72. Song Q., Schmidt A.G., Hahn H.S., Carr A.N., Frank B., Pater L., et al. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest 2003 Mar, 111(6):859-867.
73. Pan Y., Kislinger T., Gramolini A.O., Zvaritch E., Kranias E.G., MacLennan D.H., et al. Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics. Proc Natl Acad Sci USA 2004 Feb 24, 101(8):2241-2246.
74. Shai S.Y., Harpf A.E., Babbitt C.J., Jordan M.C., Fishbein M.C., Chen J., et al. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 2002 Mar 8, 90(4):458-464.
75. Haghighi K., Kolokathis F., Pater L., Lynch R.A., Asahi M., Gramolini A.O., et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 2003 Mar, 111(6):869-876.
76. Engelhardt S., Hein L., Wiesmann F., Lohse M.J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 1999 Jun 8, 96(12):7059-7064.
77. Engelhardt S., Boknik P., Keller U., Neumann J., Lohse M.J., Hein L. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor. FASEB J 2001 Dec, 15(14):2718-2720.
78. Milano C.A., Allen L.F., Rockman H.A., Dolber P.C., McMinn T.R., Chien K.R., et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 1994 Apr 22, 264(5158):582-586.
79. Schwarz B., Percy E., Gao X.M., Dart A.M., Richardt G., Du X.J. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload. Eur J Heart Fail 2003 Mar, 5(2):131-136.
80. Du X.J., Autelitano D.J., Dilley R.J., Wang B., Dart A.M., Woodcock E.A. beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation 2000 Jan 4-11, 101(1):71-77.
81. Sabri A., Rafiq K., Seqqat R., Kolpakov M.A., Dillon R., Dell'italia L.J. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog. Circ Res 2008 May 9, 102(9):1127-1136.
82. Guellich A., Gao S., Hong C., Yan L., Wagner T.E., Dhar S.K., et al. Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload. Am J Physiol Heart Circ Physiol 2010 Sep, 299(3):H707-H712.
83. Wittkopper K., Fabritz L., Neef S., Ort K.R., Grefe C., Unsold B., et al. Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. J Clin Invest 2010 Feb 1, 120(2):617-626.
84. Braz J.C., Gregory K., Pathak A., Zhao W., Sahin B., Klevitsky R., et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004 Mar, 10(3):248-254.
85. Liu Q., Chen X., Macdonnell S.M., Kranias E.G., Lorenz J.N., Leitges M., et al. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res 2009 Jul 17, 105(2):194-200.
86. Putnam A.J., Schulz V.V., Freiter E.M., Bill H.M., Miranti C.K. Src, PKCalpha, and PKCdelta are required for alphavbeta3 integrin-mediated metastatic melanoma invasion. Cell Commun Signal 2009, 7:10.
87. Triposkiadis F., Karayannis G., Giamouzis G., Skoularigis J., Louridas G., Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009 Nov 3, 54(19):1747-1762.
88. Kloner R.A., Hale S., Alker K., Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation 1992 Feb, 85(2):407-419.
89. Gianni M., Dentali F., Grandi A.M., Sumner G., Hiralal R., Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006 Jul, 27(13):1523-1529.
90. Nony P., Boissel J.P., Lievre M., Leizorovicz A., Haugh M.C., Fareh S., et al. Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis. Eur J Clin Pharmacol 1994, 46(3):191-196.